Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Novel Approach in Hypercholesterolemia Management: A Review of Phase-III Clinical Trials
- 1 January 2015
- journal article
- review article
- Published by International Scientific Information, Inc. in Medical Science Review
- Vol. 2, 8-14
- https://doi.org/10.12659/msrev.893611